The symptomatic burden of Peyronie's disease at presentation according to patient age: A critical analysis of the Peyronie's disease questionnaire (PDQ) domains
- PMID: 36426559
- DOI: 10.1111/andr.13352
The symptomatic burden of Peyronie's disease at presentation according to patient age: A critical analysis of the Peyronie's disease questionnaire (PDQ) domains
Abstract
Background: Peyronie's disease (PD) has a huge impact on patients' physical and psychological wellbeing.
Objectives: To investigate whether patients' age has an impact on PD symptomatic burden at first presentation.
Materials and methods: Data from 129 consecutive heterosexual patients seeking first medical attention for PD at a single andrological tertiary-referral centre were collected. All patients completed the International Index for Erectile Function (IIEF) and the PD questionnaire (PDQ). Descriptive statistics were used to compare clinical features between younger (≤40years) and older (>40 years) patients. Multivariable linear model assessed the impact of age, the degree of penile curvature and their impact on PDQ (total scores and its domains), after adjusting for PD duration and IIEF-erectile function domain scores.
Results: Of 129, 24 (18.6%) patients were ≤40 years old. Young patients presented with a less severe curvature than older patients (median [interquartile ranges] 20° [15-36] vs. 50° [40-80]; p = 0.04). However, younger age was associated with higher psychological and physical symptoms, PDQ-penile pain and PDQ-symptom bother scores (Coeff -0.11, -0.21 and -0.17, respectively) (all p < 0.05). Moreover, the greater the degree of curvature, the higher the PDQ-psychological and physical symptoms and the PDQ-symptom bother scores (Coeff. 0.21 and 0.22, respectively; all p < 0.05).
Conclusion: Around one in five men seeking first medical help for PD is younger than 40 years at presentation in the real-life setting. PD-related distress varies according to patients' age, with younger men presenting with a greater risk of penile pain and symptom bother despite lower curvature.
Keywords: PDQ; Peyronie's disease; age; epidemiology; young.
© 2022 American Society of Andrology and European Academy of Andrology.
References
REFERENCES
-
- Osmonov D, Ragheb A, Ward S, et al. ESSM position statement on surgical treatment of Peyronie's Disease. Sex Med. 2022;10(1):100459. doi:10.1016/j.esxm.2021.100459
-
- Hatzimouratidis K, Eardley I, Giuliano F, et al. EAU guidelines on penile curvature. Eur Urol. 2012;62(3):543-552. doi:10.1016/j.eururo.2012.05.040
-
- Salonia A, Bettocchi C, Boeri L, et al. European Association of Urology guidelines on sexual and reproductive health-2021 update: male sexual dysfunction. Eur Urol. 2021;80(3):333-357. doi:10.1016/j.eururo.2021.06.007
-
- Nehra A, Alterowitz R, Culkin DJ, et al. Peyronie's disease: AUA guideline. J Urol. 2015;194(3):745-753. 10.1016/j.juro.2015.05.098
-
- Dickstein R, Uberoi J, Munarriz R. Severe, disabling, and/or chronic penile pain associated with Peyronie disease: management with subcutaneous steroid injection. J Androl. 2010;31(5):445-449. doi:10.2164/jandrol.109.008029
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
